Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Alan K. Hatfield"'
Autor:
James R. Jett, James A. Mailliard, Michael D. Bauman, Roscoe F. Morton, Alan K. Hatfield, John W. Kugler, Ralph Levitt, Shauna Hillman, Randolph S. Marks
Publikováno v:
Cancer. 97:2498-2503
BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive-stage small cell lung carcinoma (SCLC). METHODS Patients with histologically proven, extensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9758e4968f317e1efc72b2f09cf472ce
https://doi.org/10.1002/cncr.11377
https://doi.org/10.1002/cncr.11377
Autor:
G. H. Farr, J. A. Jefferies, Vera J. Suman, Loren K. Tschetter, Nancy E Fay, Roscoe F. Morton, Alan K. Hatfield, Thomas A. Gaffey, Lynn C. Hartmann, Bobbie S. Gostout, Samir Abu-Ghazaleh, Mary M. Gallenberg
Publikováno v:
International Journal of Gynecology & Obstetrics. 74:207-210
This paper presents a randomized clinical trial of standard local ablative treatment with and without systemic interferon-alpha for cervical dysplasia. To determine the extent of the lesion study participants underwent colposcopic examination and loc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16c5258d6b0deb891d397df00f0fb3c
https://doi.org/10.1016/s0020-7292(00)00389-1
https://doi.org/10.1016/s0020-7292(00)00389-1
Autor:
Steven A. Kuross, John T. Cole, Terrence L. Cascino, James A. Mailliard, Roscoe F. Morton, Judith R. O'Fallon, William L. McGinnis, Preston D. Steen, Alan K. Hatfield, Jan C. Buckner, Paula J. Schomberg, Bernd W. Scheithauer, Albert M. Bernath
Publikováno v:
Cancer. 92:420-433
BACKGROUND The current study was conducted to determine whether the addition of interferon-α (IFN-α) to treatment with radiation therapy and carmustine (BCNU) improves time to disease progression or overall survival in patients with high-grade glio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0a3f07879c1a23222f55e2e34ff732f
https://doi.org/10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co
https://doi.org/10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co
Autor:
Richard M. Goldberg, John Kugler, Alan K. Hatfield, James A. Knost, James E. Krook, Michelle R. Mahoney, Daniel J. Sargent, Henry C. Pitot
Publikováno v:
Cancer. 89:1699-1705
BACKGROUND Topoisomerase I inhibitors have demonstrated clinical activity in patients with metastatic colorectal carcinoma. The authors performed a Phase II study to evaluate the objective tumor response rate of 2 different doses and schedules of 9-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaafb123af22e348faf66b422a1c0639
https://doi.org/10.1002/1097-0142(20001015)89:8<1699::aid-cncr8>3.0.co
https://doi.org/10.1002/1097-0142(20001015)89:8<1699::aid-cncr8>3.0.co
Autor:
Philip J. Stella, James E. Krook, James A. Mailliard, Lynn C. Hartmann, Tom R. Fitch, Edith A. Perez, James N. Ingle, Carl G. Kardinal, Suresh Nair, David W. Hillman, Alan K. Hatfield
Publikováno v:
Cancer. 88:124-131
BACKGROUND This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73d0560f35f04f26cd47f6e56b7e7521
https://doi.org/10.1002/(sici)1097-0142(20000101)88:1<124::aid-cncr17>3.0.co
https://doi.org/10.1002/(sici)1097-0142(20000101)88:1<124::aid-cncr17>3.0.co
Autor:
Bernd W. Scheithauer, S. Vincent Rajkumar, Joel M. Reid, Paul J. Novotny, P. Steven Johnson, Suresh G. Nair Md, Matthew M. Ames, James E. Krook, Roscoe F. Morton, Jan C. Buckner, Stephanie L. Safgren, Alan K. Hatfield
Publikováno v:
Journal of Neuro-Oncology. 49:255-261
We conducted a randomized phase II study to determine the efficacy of dacarbazine (DTIC) in recurrent gliomas. Patients were randomly assigned to receive either DTIC 750 mg/m2 IV day 1 every 28 days (Arm A) or DTIC 200 mg/m2 IV days 1–5 every 28 da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::120e6ad4267d0762f02af9693a65b1ba
https://doi.org/10.1023/a:1006454427026
https://doi.org/10.1023/a:1006454427026
Autor:
Terrence L. Cascino, Jeff A. Sloan, John W. Kugler, Roy Molina, Kendrith M. Rowland, Harbhajan Dhaliwal, Charles L. Loprinzi, Donald B. Wender, Chirantan Ghosh, Neil M. Ellison, Allen M. Vukov, Alan K. Hatfield, Angela W. Miser
Publikováno v:
Journal of Clinical Oncology. 15:2974-2980
PURPOSE A minority of cancer survivors develops long-term postsurgical neuropathic pain. Based on evidence that capsaicin, the pungent ingredient in hot chili peppers, might be useful for treating neuropathic pain, we developed the present clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79d5acbbcd69754b8f558a92df04d310
https://doi.org/10.1200/jco.1997.15.8.2974
https://doi.org/10.1200/jco.1997.15.8.2974
Autor:
Alan K. Hatfield, Vera J. Suman, James B. Gerstner, Lynn C. Hartmann, Patricia A. Johnson, Charles L. Loprinzi, Dean H. Gesme, John K. Camoriano, James N. Ingle, James A. Mailliard
Publikováno v:
Cancer. 80:218-224
BACKGROUND It is common practice to utilize a series of different hormonal agents in the treatment of postmenopausal women who, despite disease progression, continue to be candidates for hormonal therapy on a clinical basis. Letrozole is a new highly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05680c7bc3c13dff5ff5f2a5fa237cbe
https://doi.org/10.1002/(sici)1097-0142(19970715)80:2<218::aid-cncr8>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19970715)80:2<218::aid-cncr8>3.0.co
Autor:
Charles L. Loprinzi, Claudia Johnson, Robert A. Nelimark, John C. Michalak, Joseph E. Oesterling, Tammy Fischer, Walter W. Bate, Judith R. O'Fallon, Susan K. Quella, Raylene M. Rospond, Alan K. Hatfield, Ann Marie Dose, Nancy E. Klatt
Publikováno v:
New England Journal of Medicine. 331:347-352
Vasomotor hot flashes are a common symptom in women during menopause and in men who have undergone androgen-deprivation therapy for prostate cancer. Although treatment with estrogens in women and androgens in men can attenuate these symptoms, these h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b833a995122752fdc548d1c124a01f
https://doi.org/10.1056/nejm199408113310602
https://doi.org/10.1056/nejm199408113310602
Autor:
Lynn C. Hartmann, Michael H. Veeder, James A. Mailliard, James E. Krook, Sin-Ho Jung, James N. Ingle, Alan K. Hatfield, Dean H. Gesme, Richard M. Goldberg, John F. Foley
Publikováno v:
Cancer. 73:2337-2343
Background. The fraction of breast cancer cells undergoing DNA synthesis at any one time is relatively low, which is problematic because most chemotherapeutic agents are most effective against dividing cells. Estrogens administered in vitro and in vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4882ce6805e9e72083dcfa5208ddec35
https://doi.org/10.1002/1097-0142(19940501)73:9<2337::aid-cncr2820730916>3.0.co
https://doi.org/10.1002/1097-0142(19940501)73:9<2337::aid-cncr2820730916>3.0.co